http://www.med-discounts.com Bringing you news, articles and offers on discount medicines. Mon, 03 Mar 2008 00:39:43 +0000 http://backend.userland.com/rss092 en UroToday.com - Clinical associations have been found between BPS/IC and allergy, irritable bowel syndrome, fibromyalgia, inflammatory bowel disease, and generalized autoimmune diseases, such as systemic lupus erythematosus, rheumatoid arthritis, and Sjogren's Syndrome. Van de Merwe has studied 110 unselected BPS/IC patients and was able to make a diagnosis of ... http://www.med-discounts.com/2008/03/02/interstitial-cystitis-and-systemic-autoimmune-diseases/ To our knowledge, this is the first clinical trial to report theapplication of a major, validated, diet-based intervention as a singleform of therapy in active surveillance patients. http://www.med-discounts.com/2008/03/02/beyond-the-abstract-dietary-modification-in-patients-with-prostate-cancer-on-active-surveillance-a-randomized-multi-centre-feasibility-study/ UroToday.com - Female sexual dysfunction represents a new and underestimated field in urogynaecological research. Therefore, we provided an overview of the current literature to emphasize the growing importance and relevance of this widespread problem. http://www.med-discounts.com/2008/03/02/beyond-the-abstract-female-sexual-dysfunction-a-new-urogynaecological-research-field/ UroToday.com - The authors believe that this case series highlights a concern that was once theoretical and now appears real: the ideal screening regimen and the true incidence of malignancy in patients who have undergone bladder augmentation remain unknown. http://www.med-discounts.com/2008/03/02/beyond-the-abstract-metastatic-adenocarcinoma-after-augmentation-gastrocystoplasty/ UroToday.com - Despite two decades of experience, the clinical evaluation of the prostate cancer patient in the context of PSA screening remains controversial. Many patients today have a low risk of disease-related mortality, and there is no clear consensus for their optimal treatment or whether they should be treated ... http://www.med-discounts.com/2008/03/02/beyond-the-abstract-prostate-cancer-volume-at-biopsy-predicts-clinically-significant-upgrading/ The authors evaluated the role of Celecoxib, an inhibitor of Prostaglandin E(2) (PGE(2)), which is a potent immune modulator in the treatment of urothelial cancer. PGE(2) is known to suppress both tumour antigen-specific helper T (T(H)1) cells and the generation of cytotoxic T lymphocytes (CTLs). http://www.med-discounts.com/2008/03/02/celecoxib-has-potent-antitumour-effects-as-a-single-agent-and-in-combination-with-bcg-immunotherapy-in-a-model-of-urothelial-cell-carcinoma/ UroToday.com - A report in the December, 2007 issue of Urology by Dr. Okotie and the group of Dr. William Catalona suggests the digital rectal examination (DRE) remains an important element of prostate cancer (CaP) screening. The group performed the study, as others have suggested that DRE is no ... http://www.med-discounts.com/2008/03/02/characteristics-of-prostate-cancer-detected-by-digital-rectal-examination-only/ UroToday.com- Relationship between Endogenous Sex Hormones and Prostate Cancer Not Demonstrated in Prospective Study: Previous epidemiologic studies relating serum hormone levels to prostate cancer (CaP) risk have been inconclusive. In the International Journal of Cancer, Dr. http://www.med-discounts.com/2008/03/02/endogenous-sex-hormones-and-the-risk-of-prostate-cancer-a-prospective-study/ UroToday.com - In a report in the January 2008 issue of Qualitative Health Research, an Oxford University team of sociologists led by Alison Chapple analyzed British men's views and experiences regarding PSA screening. http://www.med-discounts.com/2008/03/02/why-men-in-the-united-kingdom-still-want-the-prostate-specific-antigen-test/ UroToday.com - This study by Decramer, et al in the October 2007 issue of World Journal of Urology looked at non-invasive markers for ureteropelvic junction obstruction to predict the necessity of pyeloplasty. It evaluated both non-invasive urinary biomarkers for UPJ obstruction as well as proteomics. http://www.med-discounts.com/2008/03/02/non-invasive-markers-of-ureteropelvic-junction-obstruction/